All Eyes on Graybug Vision! Here’s Why!
Graybug Vision, Inc. (NASDAQ: GRAY) is a clinical-stage biopharmaceutical company that is striving to create novel treatment solutions for diseases that combat vision—threatening diseases and save sight delivering a much better quality of life for patients. The Company is developing therapies for treatment of chronic...
